I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

News

Explore the latest news and resources to keep you up-to-date with women's health research, events, conferences and publications.

News

6 November 2019

DHSC: Prevention green paper open for consultation

On 22 July 2019, the Department for Health and Social Care (DHSC) published the prevention green paper, setting out proposals for the future direction of a prevention strategy.

With regards to women’s health, the green paper emphasises the important role of local authorities, acknowledging that there have been good examples of ‘creative and energetic’ commissioning.

Read article

6 November 2019

NICE: Guideline on LARC

In July 2019, the NICE Guideline on LARC [CG30] was updated to reflect the changes in commissioning and provision of contraception in England.

Any materials referring to the October 2005 guideline will need to be updated, though the changes themselves are unlikely to cause a change in current practice.

Read article

6 November 2019

DHSC: Abortion statistics 2018

DHSC has released data on abortion notifications in England and Wales for 2018, noting a substantial rise over the previous year.

The 2018 data on abortion rates have indicated that there has been an increase in the rate of abortions of 2.72% year-on-year between 2017 and 2018. However, the rise has not been universal across age groups.

Read article

6 November 2019

NICE: HMB standard update

NICE prepares for updating the NICE Quality Standard on HMB, due for publication in 2020.

In preparation for a consultation on the draft quality standard, NICE has published a topic overview on heavy menstrual bleeding. Alongside the existing core elements of the quality standard, NICE invited stakeholders to identify a maximum of five key areas for quality improvement. As these may figure into the standard.

Read article

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0268 November 2019

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Tue, 06/02/2020 - 05:23

Bayer logo